Company Filing History:
Years Active: 2006
Title: The Innovative Contributions of Kenji Ozeki in Homocysteine Measurement
Introduction
Kenji Ozeki, an esteemed inventor based in Hyogo, Japan, has made significant contributions to the field of biomedical measurement. With one registered patent to his name, Ozeki has developed a novel method that enhances the detection and measurement of homocysteine, an important biomarker in various health conditions.
Latest Patents
Ozeki's sole patent, titled "Method of measuring homocysteine," outlines a comprehensive process for detecting homocysteine levels in samples. This method involves several critical steps: firstly, it includes the reaction of a D-amino acid with a converting enzyme to create a non-substrate substance for D-amino acid oxidase or D-amino acid acetyltransferase. Subsequently, homocysteine is reduced using a thiol compound, followed by its reaction with a methyltransferase and a methyl donor to generate D-amino acid. Finally, the process involves reacting this produced D-amino acid with oxidases or acetyltransferases in the presence of a SH reagent to produce hydrogen peroxide, which is then color-developed using an oxidative color-developing agent. This innovative approach provides a more efficient means of measuring homocysteine.
Career Highlights
Kenji Ozeki is currently affiliated with Alfresa Pharma Corporation, where he continues to pursue advancements in pharmaceutical technologies and diagnostic methods. His work not only showcases his expertise as an inventor but also highlights his commitment to improving healthcare through scientific innovation.
Collaborations
Throughout his career, Ozeki has collaborated with notable colleagues such as Nobuyoshi Esaki and Tohru Yoshimura. These partnerships have likely contributed to the development and refinement of his innovative patent, leveraging collective expertise in the field.
Conclusion
Kenji Ozeki's contributions to the measurement of homocysteine are a testament to the importance of innovation in healthcare. His method presents a significant advancement in detection techniques, underscoring the vital role inventors play in addressing health challenges. As Ozeki continues his work at Alfresa Pharma Corporation, the potential for further contributions to medical science remains promising.